Innova Captab Limited — PPTs, 07-11-2024: Investor Presentation

Innova Captab Limited informed investors about the upcoming Earnings Call scheduled to discuss the unaudited financial results for the quarter and half-year ended September 30, 2024. The company has recently received a Drug Manufacturing License for its new plant in Jammu, expected to begin operations in Q3 FY25. The investor presentation highlights strong revenue growth across business segments, particularly following the acquisition of Sharon Bio-Medicine, and outlines strategic expansion plans and ongoing R&D initiatives.